Status:
COMPLETED
A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis
Lead Sponsor:
AngioLab, Inc.
Conditions:
Chronic Periodontitis
Eligibility:
All Genders
18-78 years
Phase:
PHASE2
Brief Summary
The main objective of this study is to evaluate efficacy and safety of ALH-L1005 in patients with chronic periodontitis
Eligibility Criteria
Inclusion
- Men or women ages 18 and over, under 79 years of age
- Patients diagnosed with chronic periodontitis
- Patients with 4 teeth and over whose pocket depth is ≥ 4 mm and clinical attachment level is ≥ 3 mm
- Patients who are voluntarily participated in clinical trial
Exclusion
- History of antibiotic therapy within the 1 month prior to study
- Those who had undergone any dental surgical or non-surgical therapy within 3 months prior to the start of the study
- Subjects who are pregnant/ lactating
- Smokers
- Patients who take Anticoagulants or Antiplatelet Agents
- With Systemic diseases that affect periodontal conditions such as: diabetes, hypertension and diseases of immune system
Key Trial Info
Start Date :
July 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2021
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04503746
Start Date
July 16 2020
End Date
December 13 2021
Last Update
August 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AngioLab, Inc.
Daejeon, Daejeon Gwangyeogsi, South Korea, 34015